Zai Lab Limited (ZLAB) Announces Proposed 5.5M ADS Common Offering

Go back to Zai Lab Limited (ZLAB) Announces Proposed 5.5M ADS Common Offering

Zai Lab Announces Proposed Public Offering of American Depositary Shares

January 21, 2020 4:33 PM UTC

SHANGHAI, China, and SAN FRANCISCO, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Zai Lab Limited (Zai Lab or the Company) (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of 5,500,000 American depositary shares (ADSs), each representing one ordinary share of the Company (the Primary ADS Offering). In addition, QM11 Limited, a shareholder of the Company, intends to offer 500,000 ADSs of the Company (the Secondary ADS Offering and together with the Primary ADS Offering, the Offering). Zai Lab and QM11 Limited expect to grant the underwriters... More